The Endocannabinoid System and Schizophrenia: Integration of Evidence

E-ISSN： 1873-4286|18|32|4980-4990

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.32, 2012-11, pp. : 4980-4990

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence

Current Pharmaceutical Design, Vol. 20, Iss. 13, 2014-04 ,pp. : 2089-2099

Bentham Science Publishers

Access to resources Recommend Favorite

The Endocannabinoid System and Huntington's Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 335-347

Bentham Science Publishers

Access to resources Recommend Favorite

The Endocannabinoid/Endovanilloid System and Depression

Current Neuropharmacology, Vol. 12, Iss. 5, 2014-09 ,pp. : 462-474

Bentham Science Publishers

Access to resources Recommend Favorite

The Endocannabinoid System and Pain

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-01 ,pp. : 403-421

Bentham Science Publishers

Access to resources Recommend Favorite

The Endocannabinoid System in Huntington's Disease

Current Pharmaceutical Design, Vol. 14, Iss. 23, 2008-08 ,pp. : 2317-2325

Bentham Science Publishers

Access to resources Recommend Favorite